Product References
Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib.
International journal of molecular sciences
Yamashita Y,Morita S,Hosoi H,Kobata H,Kishimoto S,Ishibashi T,Mishima H,Kinoshita A,Backes BJ,Yoshiura KI,Papa FR,Sonoki T,Tamura S
Published figure using PLK2 polyclonal antibody (Product # PA5-14094) in Immunohistochemistry
Mon Aug 31 00:00:00 UTC 2020
Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib.
International journal of molecular sciences
Yamashita Y,Morita S,Hosoi H,Kobata H,Kishimoto S,Ishibashi T,Mishima H,Kinoshita A,Backes BJ,Yoshiura KI,Papa FR,Sonoki T,Tamura S
Published figure using PLK2 polyclonal antibody (Product # PA5-14094) in Immunohistochemistry
Mon Aug 31 00:00:00 UTC 2020
Opposing action of nuclear factor κB and Polo-like kinases determines a homeostatic end point for excitatory synaptic adaptation.
The Journal of neuroscience : the official journal of the Society for Neuroscience
Mihalas AB,Araki Y,Huganir RL,Meffert MK
PA5-14094 was used in western blot to study excitory synaptic homeostatic end point adaptation and the roles played by NFkB and Polo-like kinases
Wed Oct 16 00:00:00 UTC 2013